Diseases of the Nervous- & Sensory System

Everything

Cognosci, Inc. -- About Cognosci
www.cognosci.com
Go to Cognosci home page Company About Us Management Advisors Contact Us spacer Technology APOE and Human Disease APOE and Inflammation Cognosci APOE Compounds Publications spacer Pipeline Multiple Sclerosis Alzheimer s Disease Traumatic Brain Injury spacer

Kathrynne Holden, RD on Parkinson's disease and Nutritition
www.nutritionucanlivewith.com
Books and tapes on nutrition and diet for Parkinson's disease from a Registered Dietition.

Epilepsy MiniFellowship Network
www.minifellow.net
J. Kiffin Penry Epilepsy MiniFellow Network Alumni Center History & Mission Epilepsy Education Programs Program Calendar Faculty Advisory Board Epilepsy News 20th Anniversary Video About Graylyn FAQs Supported By Epilepsy Links Contact Us J. Kiffin Penry earned an international reputation for his

Welcome To MINCEP
www.mincep.com
Physician Photo Banner Home MINCEP Making An Appointment Treatment Programs Treatment Staff Epilepsy Information Provider Services Contact Us The First Comprehensive Epilepsy Program A National Level 4 Epilepsy Center For Children, Teens And Adults Pics/livefree2.jpg Our Goal: No Seizures, No Side

Brain Study May Lead to Improved Epilepsy Treatments
www.dddmag.com
Using a rodent model of epilepsy, researchers found one of the body's own neurotransmitters released during seizures, glutamate, turns on a signaling pathway in the brain that increases production of a protein that could reduce medication entry into the brain.

Parkinson's Disease Online Radio Program to Broadcast a Special “Live” Two-Hour Event in April
www.prlog.org | Mar 26, 2010
Parkinson's Disease Online Radio Program to Broadcast a Special “Live” Two-Hour Event in April. PD Talk Live will broadcast a very special 2-hour “live” worldwide event in honor of National Parkinson's Disease Awareness Month on April 10, at 8PM (CST) on Blog Talk Radio. They will also debut a new

Autonomic Dysfunction Presenting as Postural Orthostatic Tachycardia Syndrome in Patients with
www.medsci.org | Feb 28, 2011
<p><b>Background</b>: Autonomic dysfunction is common in patients suffering from multiple sclerosis (MS) and orthostatic dizziness occurs in almost 50% of these patients. However, there have been no reports on postural orthostatic tachycardia syndrome (POTS) in patients suffering from MS.</p>

Gilenya changes multiple sclerosis landscape | Pharma Asia
www.pharmaasia.com | Oct 4, 2010
Gilenya is set to become the leading treatment in multiple sclerosis (MS) with multi-blockbuster sales, ending the decade long dominance of interferon betas and Copaxone (glatiramer acetate, Teva), says Trung Huynh, healthcare analyst, Datamonitor. The US FDA approved Novartis’s Gilenya (formally

EPILEPSY IMAGING GROUP in the Department of Clinical and Experimental Epilepsy, Institute of
www.erg.ion.ucl.ac.uk
a description of the Epilepsy Imaging Group, Department of Clinical and Experimental Epilepsy, Institute of Neurology, UCL

New epilepsy drugs overused in children | 6minutes
www.6minutes.com.au | Nov 4, 2011
There has been a sharp and unjustified rise in the use of newer and more expensive anticonvulsants in children, an Australian study has shown.